ReMed ApS: Financial statements 2022
CVR: 39182408
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
ReMed ApS (CVR 39182408) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -40,370 and a net result of DKK -197,969. Equity in the 2022 report amounted to DKK -839,460.
- Gross Profit
- DKK -40,370
- Profit/Loss
- DKK -197,969
- Equity
- DKK -839,460
- Total Assets
- DKK 5,511,566
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -40 t. | -198 t. | -839 t. | - |
| 2020 | - | -38 t. | -203 t. | -433 t. | - |
| 2019 | - | -40 t. | -183 t. | -230 t. | - |
Official annual report
Keep an eye on ReMed ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
ReMed ApS has published its interim report for the period July 1, 2020 – December 31, 2021.
About ReMed ApS
ReMed ApS is a Danish company of the type Anpartsselskab based in Rønde, founded in 2017. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The management consists of Jette Søndergaard and Jørn Aagaard. The company is owned by AAGAARD GYNÆKOLOGISK KLINIK ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -10,750 and a net result of DKK -4,608,195 compared with DKK -188,171 the year before. Equity in the 2025 report amounted to DKK -5,831,307.